Skip to main content
. 2018 Feb 8;9(17):13682–13693. doi: 10.18632/oncotarget.24455

Figure 5. Positive correlation between MET amplification and PD-L1 Expression (SP 142).

Figure 5

Patients with MET amplifications had significantly higher PD-L1 TPS (Wilcoxon rank-sum test). MET amplification versus PD-L1 expression as a continuous variable in box plot form.